Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2021
Institutional positions in Trevi Therapeutics, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- No complete 13F data for Q4 2020
- Shares held
- 13.1M
- No complete 13F data for Q4 2020
- Total value
- $35.6M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 16 | $0 | 0.00% | – | – |
| Wells Fargo & Company | 24 | $0 | 0.00% | – | – |
| Morgan Stanley | 1,000 | $3.00K | 0.00% | – | – |
| Tower Research Capital LLC (TRC) | 1,237 | $3.00K | 0.00% | – | – |
| First Manhattan Co | 1,900 | $5.00K | 0.00% | – | – |
| UBS Group AG | 2,378 | $6.00K | 0.00% | – | – |
| LPL Financial LLC | 10,000 | $27.0K | 0.00% | – | – |
| Citadel Advisors LLC | 10,617 | $29.0K | 0.00% | – | – |
| Northern Trust Corp | 11,414 | $31.0K | 0.00% | – | – |
| BlackRock Inc. | 32,394 | $87.0K | 0.00% | – | – |
| WealthTrust Axiom LLC | 38,500 | $104.0K | 0.04% | – | – |
| Geode Capital Management, LLC | 49,077 | $133.0K | 0.00% | – | – |
| Bridgeway Capital Management, LLC | 109,600 | $299.0K | 0.01% | – | – |
| Renaissance Technologies LLC | 121,849 | $330.0K | 0.00% | – | – |
| Vanguard Group Inc | 133,215 | $361.0K | 0.00% | – | – |
| FMR LLC | 576,500 | $1.57M | 0.00% | – | – |
| Omega Fund Management, LLC | 1,263,408 | $3.42M | 0.32% | – | – |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $13.1M | 0.15% | – | – |
| NEA Management Company, LLC | 5,940,796 | $16.1M | 0.36% | – | – |